Projects per year
Abstract
Inosine 5-monophosphate dehydrogenase (IMPDH) represents a potential antimicrobial drug target. The crystal structure of recombinant Pseudomonas aeruginosa IMPDH has been determined to a resolution of 2.25 angstrom. The structure is a homotetramer of subunits dominated by a (/)8-barrel fold, consistent with other known structures of IMPDH. Also in common with previous work, the cystathionine -synthase domains, residues 92204, are not present in the model owing to disorder. However, unlike the majority of available structures, clearly defined electron density exists for a loop that creates part of the active site. This loop, composed of residues 297315, links 8 and 9 and carries the catalytic Cys304. P. aeruginosa IMPDH shares a high level of sequence identity with bacterial and protozoan homologues, with residues involved in binding substrate and the NAD+ cofactor being conserved. Specific differences that have been proven to contribute to selectivity against the human enzyme in a study of Cryptosporidium parvum IMPDH are also conserved, highlighting the potential value of IMPDH as a drug target.
Original language | English |
---|---|
Pages (from-to) | 243-247 |
Number of pages | 5 |
Journal | Acta Crystallographica F-Structural Biology and Crystallization Communications |
Volume | 69 |
Issue number | 3 |
DOIs | |
Publication status | Published - 2013 |
Keywords
- DESIGN
- QUALITY
- PROTEIN
- MECHANISM
- REFINEMENT
- inosine 5-monophosphate dehydrogenase
- 5'-MONOPHOSPHATE DEHYDROGENASE
- CRYSTAL-STRUCTURE
- RESOLUTION
- INHIBITOR SELECTIVITY
- antimicrobial drug targets
- Pseudomonas aeruginosa
- DRUG DISCOVERY
Fingerprint
Dive into the research topics of 'Structure of Pseudomonas aeruginosa inosine 5-monophosphate dehydrogenase'. Together they form a unique fingerprint.Projects
- 3 Finished
-
State-of-the-Art Facilities for Structural Biology at the University of Dundee
Hunter, B. (Investigator), Lilley, D. (Investigator), Owen-Hughes, T. (Investigator), Wyatt, P. (Investigator) & van Aalten, D. (Investigator)
1/03/12 → 28/02/17
Project: Research
-
Aref#d: 19815. Wellcome Trust Centre for Drug Discovery (Strategic Award)
Fairlamb, A. (Investigator), Ferguson, M. (Investigator) & Frearson, J. (Investigator)
1/01/08 → 31/12/12
Project: Research
-
Aref#d: 19401. Structure, specificity and mechanism of biosynthetic enzymes in trypanosomatids and inhibitor discovery of essential microbial functions (Programme Grant)
Hunter, B. (Investigator)
1/11/07 → 31/12/13
Project: Research